Foundry NetDebtPrice Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1COF | CAPITAL ONE FINANCIAL CORP | Financial Services | $129.46B | 12.16% |
2BNY | BANK OF NEW YORK MELLON CORP | Financial Services | $107.85B | 10.13% |
3HOOD | ROBINHOOD MARKETS INC | Financial Services | $90.01B | 8.46% |
4APO | APOLLO GLOBAL MANAGEMENT INC | Financial Services | $69.45B | 6.53% |
5STT | STATE STREET CORP | Financial Services | $50.51B | 4.75% |
6NTRS | NORTHERN TRUST CORP | Financial Services | $34.17B | 3.21% |
7RJF | RAYMOND JAMES FINANCIAL INC | Financial Services | $32.81B | 3.08% |
8CNC | CENTENE CORP | Healthcare | $32.81B | 3.08% |
9RF | REGIONS FINANCIAL CORP | Financial Services | $27.01B | 2.54% |
10SYF | SYNCHRONY FINANCIAL | Financial Services | $24.81B | 2.33% |
11INCY | INCYTE CORP | Healthcare | $23.42B | 2.20% |
12CRCL | CIRCLE INTERNET GROUP INC | Financial Services | $15.03B | 1.41% |
13EQH | EQUITABLE HOLDINGS INC | Financial Services | $13.79B | 1.30% |
14BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $11.52B | 1.08% |
15UMBF | UMB FINANCIAL CORP | Financial Services | $11.09B | 1.04% |
16BPOP | POPULAR INC | Financial Services | $11.08B | 1.04% |
17CFR | CULLEN/FROST BANKERS INC | Financial Services | $10.15B | 0.95% |
18SSB | SOUTHSTATE BANK CORP | Financial Services | $10.08B | 0.95% |
19GME | GAMESTOP CORP | Consumer Cyclical | $9.82B | 0.92% |
20WAL | WESTERN ALLIANCE BANCORPORATION | Financial Services | $8.99B | 0.84% |
21OSCR | OSCAR HEALTH INC | Healthcare | $8.77B | 0.82% |
22KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS INC | Industrials | $8.63B | 0.81% |
23CBSH | COMMERCE BANCSHARES INC | Financial Services | $8.62B | 0.81% |
24MBLY | MOBILEYE GLOBAL INC | Consumer Cyclical | $7.76B | 0.73% |
25OKLO | OKLO INC | Utilities | $7.15B | 0.67% |
26JOBY | JOBY AVIATION INC | Industrials | $7.11B | 0.67% |
27FLR | FLUOR CORP | Industrials | $6.86B | 0.64% |
28UBSI | UNITED BANKSHARES INC | Financial Services | $6.56B | 0.62% |
29DUOL | DUOLINGO INC | Technology | $6.24B | 0.59% |
30VSEC | VSE CORP | Industrials | $5.60B | 0.53% |
31KVYO | KLAVIYO INC | Technology | $5.29B | 0.50% |
32DLB | DOLBY LABORATORIES INC | Industrials | $4.64B | 0.44% |
33EPAM | EPAM SYSTEMS INC | Technology | $4.63B | 0.44% |
34TCBI | TEXAS CAPITAL BANCSHARES INC | Financial Services | $4.59B | 0.43% |
35CATY | CATHAY GENERAL BANCORP | Financial Services | $4.20B | 0.39% |
36WSFS | WSFS FINANCIAL CORP | Financial Services | $4.16B | 0.39% |
37BETA | BETA TECHNOLOGIES INC | Industrials | $4.10B | 0.39% |
38MIAX | MIAMI INTERNATIONAL HOLDINGS INC | Financial Services | $4.02B | 0.38% |
39DYN | DYNE THERAPEUTICS INC | Healthcare | $3.92B | 0.37% |
40BANF | BANCFIRST CORP | Financial Services | $3.90B | 0.37% |
41GNW | GENWORTH FINANCIAL INC | Financial Services | $3.86B | 0.36% |
42CPRX | CATALYST PHARMACEUTICALS INC | Healthcare | $3.85B | 0.36% |
43BHF | BRIGHTHOUSE FINANCIAL INC | Financial Services | $3.77B | 0.35% |
44FHB | FIRST HAWAIIAN INC | Financial Services | $3.56B | 0.33% |
45USAR | USA RARE EARTH INC | Basic Materials | $3.49B | 0.33% |
46HG | HAMILTON INSURANCE GROUP LTD | Financial Services | $3.47B | 0.33% |
47PRK | PARK NATIONAL CORP | Financial Services | $3.43B | 0.32% |
48ONDS | ONDAS INC | Technology | $3.23B | 0.30% |
49FBK | FB FINANCIAL CORP | Financial Services | $3.09B | 0.29% |
50LEU | CENTRUS ENERGY CORP | Basic Materials | $3.07B | 0.29% |
51FRSH | FRESHWORKS INC | Technology | $3.01B | 0.28% |
52NTCT | NETSCOUT SYSTEMS INC | Technology | $2.95B | 0.28% |
53ARX | ACCELERANT HOLDINGS | Financial Services | $2.95B | 0.28% |
54AVPT | AVEPOINT INC | Technology | $2.80B | 0.26% |
55TNET | TRINET GROUP INC | Industrials | $2.74B | 0.26% |
56VISN | VISTANCE NETWORKS INC | Technology | $2.74B | 0.26% |
57FBNC | FIRST BANCORP | Financial Services | $2.67B | 0.25% |
58CUBI | CUSTOMERS BANCORP INC | Financial Services | $2.65B | 0.25% |
59IMNM | IMMUNOME INC | Healthcare | $2.53B | 0.24% |
60SLDE | SLIDE INSURANCE HOLDINGS INC | Financial Services | $2.35B | 0.22% |
61PLUS | EPLUS INC | Technology | $2.33B | 0.22% |
62YSS | YORK SPACE SYSTEMS INC | Industrials | $2.33B | 0.22% |
63RAMP | LIVERAMP HOLDINGS INC | Technology | $2.28B | 0.21% |
64HCI | HCI GROUP INC | Financial Services | $2.27B | 0.21% |
65FLYW | FLYWIRE CORP | Technology | $2.24B | 0.21% |
66HAPN | HAPPEN INC | Financial Services | $2.22B | 0.21% |
67PPTA | PERPETUA RESOURCES CORP | Basic Materials | $2.11B | 0.20% |
68LOB | LIVE OAK BANCSHARES INC | Financial Services | $1.97B | 0.18% |
69OCUL | OCULAR THERAPEUTIX INC | Healthcare | $1.96B | 0.18% |
70HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | $1.96B | 0.18% |
71DMRA | DAMORA THERAPEUTICS INC | Healthcare | $1.94B | 0.18% |
72TFIN | TRIUMPH FINANCIAL INC | Financial Services | $1.92B | 0.18% |
73MQ | MARQETA INC | Technology | $1.85B | 0.17% |
74AMR | ALPHA METALLURGICAL RESOURCES INC | Basic Materials | $1.83B | 0.17% |
75BCAX | BICARA THERAPEUTICS INC | Healthcare | $1.82B | 0.17% |
76RVLV | REVOLVE GROUP INC | Consumer Cyclical | $1.78B | 0.17% |
77DCOM | DIME COMMUNITY BANCSHARES INC | Financial Services | $1.78B | 0.17% |
78QUBT | QUANTUM COMPUTING INC | Technology | $1.76B | 0.17% |
79PLAB | PHOTRONICS INC | Technology | $1.70B | 0.16% |
80CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.67B | 0.16% |
81BFC | BANK FIRST CORP | Financial Services | $1.64B | 0.15% |
82OBK | ORIGIN BANCORP INC | Financial Services | $1.62B | 0.15% |
83INVA | INNOVIVA INC | Healthcare | $1.60B | 0.15% |
84IDT | IDT CORP | Communication Services | $1.57B | 0.15% |
85FSUN | FIRSTSUN CAPITAL BANCORP | Financial Services | $1.56B | 0.15% |
86XZO | EXZEO GROUP INC | Financial Services | $1.46B | 0.14% |
87VIA | VIA TRANSPORTATION INC | Technology | $1.46B | 0.14% |
88TRS | TRIMAS CORP | Consumer Cyclical | $1.46B | 0.14% |
89MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.14% |
90WABC | WESTAMERICA BANCORPORATION | Financial Services | $1.44B | 0.14% |
91WBTN | WEBTOON ENTERTAINMENT INC | Technology | $1.41B | 0.13% |
92OMDA | OMADA HEALTH INC | Healthcare | $1.41B | 0.13% |
93WLTH | WEALTHFRONT CORP | Technology | $1.38B | 0.13% |
94AKTS | AKTIS ONCOLOGY INC | Healthcare | $1.33B | 0.12% |
95IE | IVANHOE ELECTRIC INC | Basic Materials | $1.29B | 0.12% |
96TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | Unclassified | $1.27B | 0.12% |
97HFWA | HERITAGE FINANCIAL CORP | Financial Services | $1.26B | 0.12% |
98FCEL | FUELCELL ENERGY INC | Industrials | $1.25B | 0.12% |
99LQDT | LIQUIDITY SERVICES INC | Consumer Cyclical | $1.23B | 0.12% |
100MCB | METROPOLITAN BANK HOLDING CORP | Financial Services | $1.22B | 0.11% |
101AZTA | AZENTA INC | Healthcare | $1.21B | 0.11% |
102CCB | COASTAL FINANCIAL CORP | Financial Services | $1.20B | 0.11% |
103SDGR | SCHRODINGER INC | Healthcare | $1.14B | 0.11% |
104CRTO | CRITEO SA | Communication Services | $1.13B | 0.11% |
105WVE | WAVE LIFE SCIENCES LTD | Healthcare | $1.12B | 0.11% |
106PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | $1.09B | 0.10% |
107UVE | UNIVERSAL INSURANCE HOLDINGS INC | Financial Services | $1.09B | 0.10% |
108ESQ | ESQUIRE FINANCIAL HOLDINGS INC | Financial Services | $1.06B | 0.10% |
109FSBC | FIVE STAR BANCORP | Financial Services | $1.04B | 0.10% |
110CPF | CENTRAL PACIFIC FINANCIAL CORP | Financial Services | $1.02B | 0.10% |
111CCNE | CNB FINANCIAL CORP | Financial Services | $1.02B | 0.10% |
112BIOA | BIOAGE LABS INC | Healthcare | $1.01B | 0.10% |
113BFST | BUSINESS FIRST BANCSHARES INC | Financial Services | $1.01B | 0.09% |
114BBSI | BARRETT BUSINESS SERVICES INC | Industrials | $984M | 0.09% |
115VOR | VOR BIOPHARMA INC | Healthcare | $980M | 0.09% |
116ANRO | ALTO NEUROSCIENCE INC | Healthcare | $967M | 0.09% |
117TRST | TRUSTCO BANK CORP N Y | Financial Services | $960M | 0.09% |
118NBBK | NB BANCORP INC | Financial Services | $951M | 0.09% |
119ANNX | ANNEXON INC | Healthcare | $950M | 0.09% |
120FRBT | FORBRIGHT INC | Financial Services | $947M | 0.09% |
121ROOT | ROOT INC | Financial Services | $944M | 0.09% |
122COUR | COURSERA INC | Consumer Defensive | $941M | 0.09% |
123AOSL | ALPHA & OMEGA SEMICONDUCTOR LTD | Technology | $936M | 0.09% |
124EVER | EVERQUOTE INC | Communication Services | $925M | 0.09% |
125LBRX | LB PHARMACEUTICALS INC | Healthcare | $901M | 0.08% |
126SPFI | SOUTH PLAINS FINANCIAL INC | Financial Services | $880M | 0.08% |
127TBPH | THERAVANCE BIOPHARMA INC | Healthcare | $873M | 0.08% |
128CCBG | CAPITAL CITY BANK GROUP INC | Financial Services | $861M | 0.08% |
129MOV | MOVADO GROUP INC | Consumer Cyclical | $859M | 0.08% |
130SLDB | SOLID BIOSCIENCES INC | Healthcare | $859M | 0.08% |
131FCBC | FIRST COMMUNITY BANKSHARES INC | Financial Services | $848M | 0.08% |
132EGBN | EAGLE BANCORP INC | Financial Services | $835M | 0.08% |
133NNE | NANO NUCLEAR ENERGY INC | Industrials | $835M | 0.08% |
134HTB | HOMETRUST BANCSHARES INC | Financial Services | $824M | 0.08% |
135SMBK | SMARTFINANCIAL INC | Financial Services | $823M | 0.08% |
136AVR | ANTERIS TECHNOLOGIES GLOBAL CORP | Healthcare | $823M | 0.08% |
137HRTG | HERITAGE INSURANCE HOLDINGS INC | Financial Services | $821M | 0.08% |
138PGC | PEAPACK GLADSTONE FINANCIAL CORP | Financial Services | $817M | 0.08% |
139UMAC | UNUSUAL MACHINES INC | Industrials | $809M | 0.08% |
140SHBI | SHORE BANCSHARES INC | Financial Services | $776M | 0.07% |
141HIPO | HIPPO HOLDINGS INC | Financial Services | $764M | 0.07% |
142GDOT | GREEN DOT CORP | Financial Services | $760M | 0.07% |
143DSP | VIANT TECHNOLOGY INC | Technology | $754M | 0.07% |
144IBCP | INDEPENDENT BANK CORP | Financial Services | $750M | 0.07% |
145KODK | EASTMAN KODAK CO | Industrials | $748M | 0.07% |
146CADL | CANDEL THERAPEUTICS INC | Healthcare | $746M | 0.07% |
147IBTA | IBOTTA INC | Technology | $734M | 0.07% |
148AROW | ARROW FINANCIAL CORP | Financial Services | $687M | 0.06% |
149CASS | CASS INFORMATION SYSTEMS INC | Industrials | $686M | 0.06% |
150BCAL | CALIFORNIA BANCORP | Financial Services | $683M | 0.06% |
151TCBX | THIRD COAST BANCSHARES INC | Financial Services | $674M | 0.06% |
152SGP | SPYGLASS PHARMA INC | Healthcare | $661M | 0.06% |
153MNTN | MNTN INC | Technology | $661M | 0.06% |
154RRBI | RED RIVER BANCSHARES INC | Financial Services | $644M | 0.06% |
155TECX | TECTONIC THERAPEUTIC INC | Healthcare | $615M | 0.06% |
156NTGR | NETGEAR INC | Technology | $602M | 0.06% |
157PUBM | PUBMATIC INC | Technology | $591M | 0.06% |
158NGNE | NEUROGENE INC | Healthcare | $590M | 0.06% |
159SFST | SOUTHERN FIRST BANCSHARES INC | Financial Services | $588M | 0.06% |
160CBNK | CAPITAL BANCORP INC | Financial Services | $584M | 0.05% |
161STTK | SHATTUCK LABS INC | Healthcare | $577M | 0.05% |
162GLRE | GREENLIGHT CAPITAL RE LTD | Financial Services | $566M | 0.05% |
163IMMX | IMMIX BIOPHARMA INC | Healthcare | $558M | 0.05% |
164HBCP | HOME BANCORP INC | Financial Services | $544M | 0.05% |
165VSTM | VERASTEM INC | Healthcare | $530M | 0.05% |
166EROC | EAGLE ROCK ENERGY PARTNERS L P | Energy | $520M | 0.05% |
167ZURA | ZURA BIO LTD | Healthcare | $518M | 0.05% |
168ARVN | ARVINAS INC | Healthcare | $517M | 0.05% |
169OBT | ORANGE COUNTY BANCORP INC | Financial Services | $504M | 0.05% |
170SD | SANDRIDGE ENERGY INC | Energy | $503M | 0.05% |
171ACIC | AMERICAN COASTAL INSURANCE CORP | Financial Services | $497M | 0.05% |
172BSVN | BANK7 CORP | Financial Services | $485M | 0.05% |
173GDYN | GRID DYNAMICS HOLDINGS INC | Technology | $484M | 0.05% |
174BWFG | BANKWELL FINANCIAL GROUP INC | Financial Services | $479M | 0.05% |
175PAYS | PAYSIGN INC | Technology | $478M | 0.04% |
176BMRC | BANK OF MARIN BANCORP | Financial Services | $468M | 0.04% |
177CWCO | CONSOLIDATED WATER CO LTD | Utilities | $467M | 0.04% |
178IPI | INTREPID POTASH INC | Basic Materials | $459M | 0.04% |
179PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $453M | 0.04% |
180GBFH | GBANK FINANCIAL HOLDINGS INC | Financial Services | $445M | 0.04% |
181BNTC | BENITEC BIOPHARMA INC | Healthcare | $439M | 0.04% |
182PBFS | PIONEER BANCORP INC | Financial Services | $431M | 0.04% |
183CCRN | CROSS COUNTRY HEALTHCARE INC | Healthcare | $428M | 0.04% |
184PCB | PCB BANCORP | Financial Services | $424M | 0.04% |
185TENX | TENAX THERAPEUTICS INC | Healthcare | $420M | 0.04% |
186CBIO | CRESCENT BIOPHARMA INC | Healthcare | $407M | 0.04% |
187MCFT | MASTERCRAFT BOAT HOLDINGS INC | Consumer Cyclical | $407M | 0.04% |
188USNA | USANA HEALTH SCIENCES INC | Consumer Defensive | $403M | 0.04% |
189STRO | SUTRO BIOPHARMA INC | Healthcare | $391M | 0.04% |
190FCBM | FIRST CAROLINA FINANCIAL SERVICES INC | Financial Services | $389M | 0.04% |
191UPB | UPSTREAM BIO INC | Healthcare | $382M | 0.04% |
192MVBF | MVB FINANCIAL CORP | Financial Services | $377M | 0.04% |
193WEYS | WEYCO GROUP INC | Consumer Cyclical | $374M | 0.04% |
194BBBY | BED BATH & BEYOND INC | Consumer Cyclical | $372M | 0.03% |
195BCML | BAYCOM CORP | Financial Services | $371M | 0.03% |
196GNE | GENIE ENERGY LTD | Utilities | $369M | 0.03% |
197AII | AMERICAN INTEGRITY INSURANCE GROUP INC | Financial Services | $366M | 0.03% |
198NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | $359M | 0.03% |
199AVBH | AVIDBANK HOLDINGS INC | Financial Services | $353M | 0.03% |
200STRT | STRATTEC SECURITY CORP | Consumer Cyclical | $344M | 0.03% |
201TSBK | TIMBERLAND BANCORP INC | Financial Services | $343M | 0.03% |
202MTRX | MATRIX SERVICE CO | Industrials | $342M | 0.03% |
203SEG | SEAPORT ENTERTAINMENT GROUP INC | Real Estate | $332M | 0.03% |
204RTAC | RENATUS TACTICAL ACQUISITION CORP I | Industrials | $329M | 0.03% |
205MPTI | M-TRON INDUSTRIES INC | Technology | $328M | 0.03% |
206VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.03% |
207NODK | NI HOLDINGS INC | Financial Services | $326M | 0.03% |
208COSO | COASTALSOUTH BANCSHARES INC | Financial Services | $326M | 0.03% |
209BKKT | BAKKT INC | Technology | $323M | 0.03% |
210MYFW | FIRST WESTERN FINANCIAL INC | Financial Services | $323M | 0.03% |
211FVCB | FVCBANKCORP INC | Financial Services | $321M | 0.03% |
212CARL | CARLSMED INC | Healthcare | $317M | 0.03% |
213MKTW | MARKETWISE INC | Technology | $314M | 0.03% |
214JMSB | JOHN MARSHALL BANCORP INC | Financial Services | $313M | 0.03% |
215LYEL | LYELL IMMUNOPHARMA INC | Healthcare | $311M | 0.03% |
216CIX | COMPX INTERNATIONAL INC | Industrials | $309M | 0.03% |
217FCCO | FIRST COMMUNITY CORP | Financial Services | $307M | 0.03% |
218FHTX | FOGHORN THERAPEUTICS INC | Healthcare | $305M | 0.03% |
219FDBC | FIDELITY D & D BANCORP INC | Financial Services | $305M | 0.03% |
220OFLX | OMEGA FLEX INC | Industrials | $302M | 0.03% |
221FNRN | FIRST NORTHERN COMMUNITY BANCORP | Financial Services | $300M | 0.03% |
222NL | NL INDUSTRIES INC | Industrials | $288M | 0.03% |
223OVLY | OAK VALLEY BANCORP | Financial Services | $282M | 0.03% |
224MASS | 908 DEVICES INC | Healthcare | $278M | 0.03% |
225CBNA | CHAIN BRIDGE BANCORP INC | Financial Services | $275M | 0.03% |
226SGHT | SIGHT SCIENCES INC | Healthcare | $274M | 0.03% |
227CEPO | CANTOR EQUITY PARTNERS I INC | Industrials | $271M | 0.03% |
228ALMU | AELUMA INC | Technology | $267M | 0.03% |
229FXNC | FIRST NATIONAL CORP | Financial Services | $267M | 0.03% |
230BPRN | PRINCETON BANCORP INC | Financial Services | $263M | 0.02% |
231ATLO | AMES NATIONAL CORP | Financial Services | $262M | 0.02% |
232LTBR | LIGHTBRIDGE CORP | Industrials | $256M | 0.02% |
233SNFCA | SECURITY NATIONAL FINANCIAL CORP | Financial Services | $255M | 0.02% |
234QTTB | Q32 BIO INC | Healthcare | $255M | 0.02% |
235SRZN | SURROZEN INC | Healthcare | $255M | 0.02% |
236VNME | VENDOME ACQUISITION CORP I | Industrials | $254M | 0.02% |
237VABK | VIRGINIA NATIONAL BANKSHARES CORP | Financial Services | $250M | 0.02% |
238RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | $243M | 0.02% |
239SOCA | SOLARIUS CAPITAL ACQUISITION CORP | Industrials | $241M | 0.02% |
240GENC | GENCOR INDUSTRIES INC | Industrials | $235M | 0.02% |
241USAU | US GOLD CORP | Basic Materials | $235M | 0.02% |
242NKSH | NATIONAL BANKSHARES INC | Financial Services | $233M | 0.02% |
243INBK | FIRST INTERNET BANCORP | Financial Services | $233M | 0.02% |
244PEBK | PEOPLES BANCORP OF NORTH CAROLINA INC | Financial Services | $232M | 0.02% |
245EFSI | EAGLE FINANCIAL SERVICES INC | Financial Services | $229M | 0.02% |
246CZWI | CITIZENS COMMUNITY BANCORP INC | Financial Services | $224M | 0.02% |
247OPBK | OP BANCORP | Financial Services | $223M | 0.02% |
248UTMD | UTAH MEDICAL PRODUCTS INC | Healthcare | $222M | 0.02% |
249CFBK | CF BANKSHARES INC | Financial Services | $215M | 0.02% |
250KROS | KEROS THERAPEUTICS INC | Healthcare | $211M | 0.02% |
251GSIT | GSI TECHNOLOGY INC | Technology | $208M | 0.02% |
252RNA | ATRIUM THERAPEUTICS INC | Healthcare | $208M | 0.02% |
253IMUX | IMMUNIC INC | Healthcare | $207M | 0.02% |
254OVBC | OHIO VALLEY BANC CORP | Financial Services | $206M | 0.02% |
255AIRO | AIRO GROUP HOLDINGS INC | Industrials | $205M | 0.02% |
256FCAP | FIRST CAPITAL INC | Financial Services | $205M | 0.02% |
257DTIL | PRECISION BIOSCIENCES INC | Healthcare | $203M | 0.02% |
258AMWL | AMERICAN WELL CORP | Healthcare | $199M | 0.02% |
259TNXP | TONIX PHARMACEUTICALS HOLDING CORP | Healthcare | $198M | 0.02% |
260RBKB | RHINEBECK BANCORP INC | Financial Services | $190M | 0.02% |
261FINW | FINWISE BANCORP | Financial Services | $189M | 0.02% |
262BVFL | BV FINANCIAL INC | Financial Services | $186M | 0.02% |
263ACOG | ALPHA COGNITION INC | Healthcare | $185M | 0.02% |
264EGAN | EGAIN CORP | Technology | $180M | 0.02% |
265HNVR | HANOVER BANCORP INC | Financial Services | $179M | 0.02% |
266INGN | INOGEN INC | Healthcare | $178M | 0.02% |
267KVHI | KVH INDUSTRIES INC | Technology | $178M | 0.02% |
268ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.02% |
269NLOP | NET LEASE OFFICE PROPERTIES | Real Estate | $172M | 0.02% |
270MNSB | MAINSTREET BANCSHARES INC | Financial Services | $172M | 0.02% |
271SBFG | SB FINANCIAL GROUP INC | Financial Services | $170M | 0.02% |
272CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | Healthcare | $167M | 0.02% |
273NUCL | EAGLE NUCLEAR ENERGY CORP | Basic Materials | $166M | 0.02% |
274FGBI | FIRST GUARANTY BANCSHARES INC | Financial Services | $164M | 0.02% |
275LENZ | LENZ THERAPEUTICS INC | Healthcare | $162M | 0.02% |
276OWLT | OWLET INC | Healthcare | $162M | 0.02% |
277TRAK | REPOSITRAK INC | Technology | $160M | 0.02% |
278FNWD | FINWARD BANCORP | Financial Services | $157M | 0.01% |
279EXOD | EXODUS MOVEMENT INC | Technology | $152M | 0.01% |
280UNCY | UNICYCIVE THERAPEUTICS INC | Healthcare | $144M | 0.01% |
281HURC | HURCO COMPANIES INC | Industrials | $142M | 0.01% |
282AFBI | AFFINITY BANCSHARES INC | Financial Services | $139M | 0.01% |
283ACNT | ASCENT INDUSTRIES CO | Basic Materials | $138M | 0.01% |
284PMN | PROMIS NEUROSCIENCES INC | Healthcare | $136M | 0.01% |
285AXR | AMREP CORP | Real Estate | $136M | 0.01% |
286LSBK | LAKE SHORE BANCORP INC | Financial Services | $135M | 0.01% |
287FIRY | FIRY INC | Technology | $130M | 0.01% |
288VTVT | VTV THERAPEUTICS INC | Healthcare | $130M | 0.01% |
289AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.01% |
290JYNT | JOINT CORP | Healthcare | $127M | 0.01% |
291BUDA | BUDA JUICE INC | Unclassified | $121M | 0.01% |
292BOTJ | BANK OF THE JAMES FINANCIAL GROUP INC | Financial Services | $121M | 0.01% |
293SFBC | SOUND FINANCIAL BANCORP INC | Financial Services | $120M | 0.01% |
294SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.01% |
295NCSM | NCS MULTISTAGE HOLDINGS INC | Energy | $114M | 0.01% |
296MED | MEDIFAST INC | Consumer Cyclical | $114M | 0.01% |
297CODA | CODA OCTOPUS GROUP INC | Industrials | $113M | 0.01% |
298RVSB | RIVERVIEW BANCORP INC | Financial Services | $107M | 0.01% |
299ROC | RANK ONE COMPUTING CORP | Technology | $98M | 0.01% |
300VRCA | VERRICA PHARMACEUTICALS INC | Healthcare | $96M | 0.01% |
301FDSB | FIFTH DISTRICT BANCORP INC | Financial Services | $94M | 0.01% |
302AUBN | AUBURN NATIONAL BANCORPORATION INC | Financial Services | $93M | 0.01% |
303FUSB | FIRST US BANCSHARES INC | Financial Services | $92M | 0.01% |
304MHH | MASTECH DIGITAL INC | Industrials | $89M | 0.01% |
305GEOS | GEOSPACE TECHNOLOGIES CORP | Energy | $88M | 0.01% |
306RLYB | RALLYBIO CORP | Healthcare | $87M | 0.01% |
307CPBI | CENTRAL PLAINS BANCSHARES INC | Industrials | $85M | 0.01% |
308WATT | ENERGOUS CORP | Technology | $83M | 0.01% |
309FRMM | FORUM MARKETS INC | Healthcare | $83M | 0.01% |
310CSPI | CSP INC | Technology | $82M | 0.01% |
311CPHC | CANTERBURY PARK HOLDING CORP | Consumer Cyclical | $82M | 0.01% |
312HNNA | HENNESSY ADVISORS INC | Financial Services | $79M | 0.01% |
313ROLR | HIGH ROLLER TECHNOLOGIES INC | Consumer Cyclical | $76M | 0.01% |
314ACET | ADICET BIO INC | Healthcare | $76M | 0.01% |
315BODI | BEACHBODY COMPANY INC | Communication Services | $75M | 0.01% |
316OPHC | OPTIMUMBANK HOLDINGS INC | Financial Services | $74M | 0.01% |
317NSTS | NSTS BANCORP INC | Financial Services | $73M | 0.01% |
318HFBL | HOME FEDERAL BANCORP INC OF LOUISIANA | Financial Services | $70M | 0.01% |
319LNSR | LENSAR INC | Healthcare | $70M | 0.01% |
320CLST | CATALYST BANCORP INC | Financial Services | $70M | 0.01% |
321LONA | LEONABIO INC | Healthcare | $68M | 0.01% |
322BGSF | BGSF INC | Industrials | $65M | 0.01% |
323IMA | IMAGENEBIO INC | Healthcare | $61M | 0.01% |
324EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.01% |
325SGA | SAGA COMMUNICATIONS INC | Communication Services | $58M | 0.01% |
326TACT | TRANSACT TECHNOLOGIES INC | Technology | $54M | 0.01% |
327INKT | MINK THERAPEUTICS INC | Healthcare | $53M | 0.00% |
328XLO | XILIO THERAPEUTICS INC | Healthcare | $53M | 0.00% |
329APT | ALPHA PRO TECH LTD | Basic Materials | $53M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $1.06T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 85% toward Large, 46% toward Growth. +2% unclassified (12 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 329 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual50.8%Margin-25.8%Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 329 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 24%; both still land on the same side of the 2x limit.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 23.4% | -11.5% |
| 3 yearsp.a. | 24.3% | 0.3% |
| 5 yearsp.a. | 14.5% | -0.3% |
| 10 yearsp.a. | 14.6% | -1.6% |
| Since inceptionp.a. | 10.2% | 1.9% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 11.8% | -5.6% |
| 2025 | 29.9% | 2.3% |
| 2024 | 24.0% | 3.7% |
| 2023 | 17.8% | -4.1% |
| 2022 | -13.8% | 0.5% |
| 2021 | 29.0% | -8.1% |
| 2020 | 17.3% | 4.2% |
| 2019 | 12.4% | -14.9% |
| 2018 | -12.0% | 4.0% |
| 2017 | 20.8% | 6.2% |
| 2016 | 15.2% | -5.5% |
| 2015 | -4.0% | 13.7% |
| 2014 | 9.2% | 2.3% |
| 2013 | 50.7% | 10.0% |
| 2012 | 17.4% | -14.0% |
| 2011 | -14.4% | 4.9% |
| 2010 | 13.3% | -3.4% |
| 2009 | 41.7% | -1.1% |
| 2008 | -40.8% | 30.8% |
| 2007 | 6.8% | 33.1% |
| 2006 | 23.5% | -1.2% |
| 2005 | 13.2% | 9.4% |
| 2004 | 20.3% | 7.0% |
| 2003 | 59.5% | 9.8% |
| 2002 | -21.8% | -0.8% |
| 2001 | -8.1% | -4.3% |
| 2000 | -16.1% | -33.0% |
| 1999 | 46.9% | 32.5% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry NetDebtPrice Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a NetDebtPrice signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.